In a significant step for the internationalization of national science and biomedical research, Centro Ciencia & Vida—an organization linked to Fundación Ciencia & Vida and Universidad San Sebastián—and the Institute for Research and Innovation in Health (i3S) of the University of Porto, Portugal, have formalized an agreement that establishes a solid framework for collaboration designed to integrate the complementary competencies of both institutions and address global challenges in health and biotechnology.

This alliance stems from the mutual recognition of each center's strengths. On one hand, i3S has consolidated itself in Europe as a leading non-profit organization in the life sciences, dedicated to solving critical problems of today's society, such as aging, infectious diseases, cancer, regenerative medicine, and neurodegenerative diseases.

Its model seeks not only high-standard research but also to foster an environment that favors technology transfer and strong interaction with hospitals and industries.

For its part, Centro Ciencia & Vida contributes its distinctive “Science 360” approach and experience, a philosophy that encompasses everything from scientific research and advanced human capital training to technology transfer and biotechnology entrepreneurship. Centro Ciencia & Vida promotes the development of society through science, creating opportunities for global partnerships and international networks, elements that will now be enhanced by this link with the Portuguese health research and innovation institute, i3S.

Scope and axes of the collaboration

The central purpose of the agreement is to promote cooperation in priority areas for both institutions. The agreement details multiple avenues for joint action that include, but are not limited to:

Joint research development: creation of collaborative projects and proposals focused on scientific and health priorities shared between Chile and Portugal.

Academic innovation and double degrees: design and implementation of collaborative courses, seminars, and academic and professional programs. A highlight of the agreement is the possibility of developing joint degree or double degree programs, which would directly benefit students and researchers in training.

Human capital exchange: the exchange of experience, technical personnel, and resource capabilities will be facilitated, allowing researchers from both sides of the Atlantic to share laboratories and knowledge.

Dissemination and scientific meetings: joint organization of conferences, symposiums, and academic meetings to foster multilateral efforts that support the advancement of life sciences and technology, ensuring the dissemination of these advances to diverse audiences.

Next stages of the agreement

To ensure the success of this alliance, a clear coordination structure has been established. Dr. Álvaro Lladser, director of Centro Ciencia & Vida, and Dr. Claudio Sunkel, director of i3S, will act as the main liaisons for the implementation of the agreement's activities.

This agreement not only links two research institutes but also connects innovation ecosystems in Latin America and Europe, opening opportunities for shared funding, mobility for young researchers, and an acceleration in the search for solutions to complex diseases through the combination of talent and cutting-edge technology.